"Sputnik V Works Well Against Covid Mutations": Russian Direct Investment Fund CEO
"We believe Sputnik V works very well against different mutations of the virus. We have proved that it will work well for future strains as well; we expect approval from the Indian government in the next couple of weeks", says Kirill Dmitriev, CEO of Russian Direct Investment Fund, on partnering with an India-based drug-maker for the production of 200 million doses of the vaccine against the coronavirus.
